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Edited by Robert BaroukiAbstract Bile acids and other steroids modify large conduc-
tance, calcium- and voltage-gated potassium (BK) channel activ-
ity contributing to non-genomic modulation of myogenic tone.
Accessory BK b1 subunits are necessary for lithocholate (LC)
to activate BK channels and vasodilate. The protein regions that
sense steroid action, however, remain unknown. Using recombi-
nant channels in 1-palmitoyl-2-oleoyl-phosphatidylethanolamine/
1-palmitoyl-2-oleoyl-phosphatidylserine bilayers we now demon-
strate that complex proteolipid domains and cytoarchitecture
are unnecessary for b1 to mediate LC action; b1 and a simple
phospholipid microenvironment suﬃce. Since b1 senses LC but
b4 does not, we made chimeras swapping regions between these
subunits and, following channel heterologous expression, demon-
strate that b1 TM2 is a bile acid-recognizing sensor.
 2008 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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In most vertebrates, including humans, bile acids are synthe-
sized from cholesterol and facilitate digestion and absorption
of dietary lipids. These processes involve bile acid interactions
with membrane and cytosolic proteins, requiring speciﬁc bile
acid-recognition domains in the proteins themselves [1–3].
Besides their well-established role in gastrointestinal physio-
logy and disease, bile acids are increasingly recognized as
multifunctional signaling molecules, and a variety of bile acid
receptor proteins have emerged. Bile acids are natural ligands
of the farnesoid-X receptor, a transcription factor that con-
trols genes involved in bile acid and cholesterol homeostasis
[4]. Bile acids are ligands of the G-protein-coupled receptor
TGR5 [5], and activators of MAP kinase. Thus, these steroids
possess endocrine functions, controlling energy use and bodyAbbreviations: LC, lithocholate; BK, large conductance, calcium- and
voltage-gated potassium; POPE, 1-palmitoyl-2-oleoyl-phosphatidyl-
ethanolamine; POPS, 1-palmitoyl-2-oleoyl-phosphatidylserine; DMSO,
dimethyl sulfoxide (DMSO); N, number of channels present in the
membrane patch/lipid bilayer; Po, channel open probability; Ibtx,
iberiotoxin
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doi:10.1016/j.febslet.2008.01.036weight [6]. In addition, bile acids activate vitamin D receptors
[7] and facilitate internal Ca2+ mobilization via ryanodine and
IP3 receptors [8], which makes these steroids active players in
Ca2+ homeostasis. In spite of the growing list of proteins that
recognize bile acids as endogenous ligands, the identiﬁcation
of speciﬁc bile acid-recognition domains in these receptor
proteins remains largely elusive.
It has been known for decades that lithocholate (LC) and
other bile acids are eﬀective vasodilators in human physiology
and disease [9,10]. In a recent study, we demonstrated that LC-
induced vasodilation is blunted after genetic ablation of
KCNMB1, which codes for the b1 subunit of the large conduc-
tance, calcium- and voltage-gated potassium (BK) channel
[11], a channel that critically controls vascular tone [12,13].
In most tissues, BK channels are heterooligomers consisting
of pore-forming (a, encoded by slo1), and accessory (b1–b4)
subunits, with b1 being abundant in smooth muscle [13]. Stud-
ies in cell-free membrane patches demonstrate that b1 expres-
sion is necessary for LC to increase the activity of BK
channels cloned from arterial myocytes [11].
Natural membranes, however, are complex organelles, with
a myriad of molecular entities [14] that can mediate or, at least,
modify, the bile acid-channel interaction. Whether LC-sensing
by BK b1 requires the complex proteolipid environment of
natural cell membranes or, rather, the BK channel and its
immediate, simple lipid medium suﬃce, remains unknown.
We addressed this question and identiﬁed the speciﬁc BK b1
protein domain that recognizes LC leading to channel activation.2. Materials and methods
2.1. Bilayer experiments
BK a cDNA (‘‘cbv1’’) was cloned from rat cerebral artery myocytes
(AY330293, [15]). BK b1 cDNA was a generous gift from Maria Gar-
cia (Merck, Whitehouse station, NJ). HEK293 cells transiently trans-
fected with cbv1 or cbv1 + BK b1 cDNAs were grown to conﬂuence,
pelleted, and resuspended on ice in 10 ml of buﬀer solution (mM): 30
KCl, 2 MgCl2, 10 HEPES, 5 EGTA; pH 7.2. A membrane preparation
was obtained using a sucrose gradient as described elsewhere [16], and
aliquots were stored at 80 C.
Channels were incorporated by adding 10–15 ll of membrane prepa-
ration onto bilayers cast of 1-palmitoyl-2-oleoyl-phosphatidylethanol-
amine (POPE) and 1-palmitoyl-2-oleoyl-phosphatidylserine (POPS),
3:1 (w/w). LC and cholesterol were introduced into the lipid mixture
at ﬁnal concentrations of 33% and 5–37 mol%, respectively. Lipids
were dried under N2 gas and resuspended in 25 mg/ml decane. Vertical,
80–120 pF bilayers were formed by painting the lipid mix across
a 200 lm hole in a deldrin cup (Warner, Hamden, CT). Vesicle
fusion was promoted by osmosis, with the cis chamber (to which the
membrane preparation was added) being hyperosmotic to the trans.blished by Elsevier B.V. All rights reserved.
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1.05 CaCl2 ðCa2þfree ﬃ 10 lMÞ, pH 7.2; trans, 30 KCl, 10 HEPES, 0.1
HEDTA, pH 7.2. Currents were obtained at 0 mV using a bilayer
ampliﬁer (Warner BC-525D), low-pass ﬁltered at 1 and sampled at
5 kHz using Digidata 1322 A and pCLAMP 8.0 (Molecular Devices,
Union City, CA).
2.2. Xenopus oocyte experiments
Cbv1 cDNA ligated to the PCR-XL-TOPO cloning vector (Invitro-
gen, Carlsbad, CA) was cleaved by BamHI (Invitrogen) and XhoI
(Promega, Madison, WI), and inserted into pOX for expression in
Xenopus laevis oocytes. pOX-cbv1 was linearized with NotI (Promega)
and transcribed in vitro using T3 (Ambion, Austin, TX). pOX was a
generous gift from Aguan Wei (Washington University, Saint Louis,
MO).
b1/b4 chimeric cDNAs were constructed using overlap extension or
custom synthesized (IDT, Coralville, IA), subcloned in pOx or
pcDNA3, linearized, and transcribed in vitro using T3 or T7 RNA
polymerase (Ambion). Sequences of cDNA constructs were deter-
mined at the University of Tennessee Molecular Research Center.
cRNA was dissolved in diethyl polycarbonate-treated water at 5
(cbv1) and 15 (b1, b4 or chimeras) ng/ll; 1 ll aliquots were stored at
70 C. X. laevis (NASCO, Fort Atkinson, WI; Xenopus Xpress,
Plant City, FL) oocytes were isolated as described [17]. Cbv1 cRNA
was injected alone (2.5 ng/ll) or with chimeric b1/b4 (7.5 ng/ll) cRNAs,
giving molar ratios P6:1 (b:a). cRNA injection (23 nl/oocyte) was
conducted using a modiﬁed micropipette (Drummond, Broomall,
PA) 48–72 h before patch-clamp recordings. Oocytes were prepared
for patch-clamping as described [17].
Currents were recorded from inside-out (I/O) or outside-out (O/O)
patches using an EPC8 ampliﬁer (HEKA, Lambrecht/Pfalz, Germany)
at 1 kHz using a low-pass, eight-pole Bessel ﬁlter (902LPF, Fre-
quency Devices, Haverhill, MA). Data were sampled at 5 kHz
using Digidata 1320A and pCLAMP 8.0 (Molecular Devices). Bath
and electrode solutions contained (mM): 135 K+ gluconate, 5 EGTA,
1 MgCl2, 0.01 CaCl2, 15 HEPES, 10 glucose, pH 7.35. Free Ca
2+ was
calculated with MaxChelator Sliders and determined using Ca2+-selec-
tive electrodes. Patch-recording and ground electrodes were made as
described [17]. Bath solution containing either vehicle or 150 lM LC
was applied onto excised patches using a pressurized DAD12 system
(ALA, New York, NY). Experiments were carried out at room temper-
ature.
2.3. Chemicals
5b-Cholanic acid 3a-ol (LC) and iberiotoxin (Ibtx) were purchased
from Steraloids (Newport, RI) and Alomone (Jerusalem, Israel),
respectively. All other chemicals were purchased from Sigma (St.
Louis, MO). On the day of the experiment, an LC stock solution
(333 mM) in dimethyl sulfoxide (DMSO) was freshly prepared by
sonication for 5 min. For oocyte recordings, the LC stock solution
was diluted 1/10 in 95% ethanol, and further diluted in bath solution
to ﬁnal concentration. The DMSO/ethanol vehicle in bath solution
(60.05/60.45%) was used as control (before) and wash of (after) LC
application.2.4. Data analysis
Data were analyzed with pCLAMP 8.0 (Molecular Devices). As
index of channel activity we used the product of the number of chan-
nels in the patch/bilayer (N) and the channel open probability (Po).
NPo was obtained from all-points amplitude histograms [17] from
P30 s of continuous recording under each experimental condition.
Further analysis, plotting and ﬁtting were conducted using Origin
7.0 (Originlab, Northampton, MA) and InStat 3.0 (GraphPad
Software, San Diego, CA). Statistical analysis was conducted using
one-way ANOVA and Bonferronis multiple comparison test; signiﬁ-
cance was set at P < 0.05. Data are expressed as means ± S.E.M.;
n = number of patches/bilayers.3. Results
We ﬁrst determined whether the complex proteolipid envi-
ronment of natural cell membranes is necessary for BK b1sensing of LC. Thus, we probed LC on homomeric cbv1
and heteromeric cbv1 + b1 channels that were reconstituted
into planar 3:1 POPE:POPS (w/w) bilayers. We chose this
binary bilayer to validate basal channel behavior with our
previous characterization of native skeletal muscle BK
channels [18] and recombinant slo1 from human brain [16]
reconstituted into this bilayer type. Upon cbv1 channel incor-
poration, we recorded unitary current events that displayed
distinct features of BK channel openings: large current ampli-
tude (e.g., 14 pA at 0 mV in 300/30 mM [K+]i/[K
+]o; Fig. 1A);
increase in Po as voltage was made more positive (Supple-
mentary Fig. 1A), and/or [Ca2+]i was increased (not shown).
Within a wide voltage range (60 to 0 mV), cbv1 channels
required more Ca2þi to achieve a given (N)Po than that
required by cbv1 + b1 (Fig. 1A left vs. right panels). This
demonstrates that b1 increases the channel apparent Ca
2+-
sensitivity, as previously shown for other slo1 channels [19].
The increase resulted in a parallel leftward shift in the
V–Po plot (Supplementary Fig. 1A), and served to indicate
the presence of functional BK b1.
LC was introduced into the lipid mix at 20% (w/w), which
corresponds to a molar fraction of 0.33. This is roughly equiv-
alent to 300 lM LC in the aqueous phase, a concentration that
is fully eﬀective to activate native and recombinant BK chan-
nels [10,11]. Cbv1 + b1 NPo in POPE/POPS bilayers contain-
ing LC were consistently higher than those in LC absence
(Fig. 1A, right). The increased NPo in LC far exceeds any pos-
sible maximum due to NPo spontaneous oscillations found in
POPE/POPS alone (Supplementary Fig. 1B). Furthermore, the
average increase in NPo (·3, n = 3) induced by LC was iden-
tical to that observed when LC 150–300 lM was applied to
native cerebral artery BK channels or to cbv1 + b1 expressed
in oocytes [11]. In contrast, cbv1 NPo remained insensitive
to LC presence in the bilayer (Fig. 1A, left; Fig. 1B) (n = 5),
mimicking the LC-refractoriness of cbv1 expressed in natural
membranes [11]. Collectively, these results indicate that com-
plex membrane cytoarchitecture and heterogeneous proteo-
lipid domains are unnecessary for b1 to mediate LC action
on BK channels. Rather, cbv1 + b1 and a simple phospholipid
microenvironment are suﬃcient.
On the other hand, as previously shown with brain BK
channels [20] and hslo1 [16] reconstituted into binary phospho-
lipid bilayers, 33 mol% cholesterol consistently inhibited cbv1
channels (Fig. 1A and B). The decrease in cbv1 steady-stated
activity (Po) was a monotonic function of cholesterol concen-
tration in the bilayer (IC50  20 mol%). This reduction in Po
was evident at cholesterol levels present in natural membranes
(7.5–50 mol% of total lipid), with cbv1 Po reaching minimum
values at 33–37 mol% cholesterol (Supplementary Fig. 2).
Notably, cbv1 + b1 channels displayed a cholesterol response
identical to that of cbv1 (Fig. 1B). Thus, b1 are required
for LC, but not cholesterol, modulation of BK channels in
simple, binary bilayers. Conceivably, this speciﬁcity involves
LC-recognition by speciﬁc protein domains, leading to the
hypothesis that a region(s) in BK b1 behaves as a speciﬁc
LC-sensor.
Based on the fact that b1, but not b4, confers LC sensitivity
to the BK channel [11], we constructed chimeric b1/b4 (termed
‘‘B1L4’’ and ‘‘B4L1’’) where the extracellular loops were
swapped (Fig. 2A; Supplementary Fig. 3). After chimeric
subunit coexpression with cbv1 in X. oocytes, we probed
LC action on Po using conditions similar to those used to
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Fig. 1. Lithocholic acid activates BK channels in binary phospholipid bilayers. (A) Currents obtained after incorporation of cbv1 + b1 (right) or cbv1
(left) channels into POPE:POPS 3:1 (w/w) bilayers in the absence (top) or presence of lithocholate (middle) or cholesterol (bottom);
arrows = baseline. (B) Averaged responses of cbv1 (left) and cbv1 + b1 (right) to the steroid presence. In A and B: [steroids] = 33 mol%;
V = 0 mV; free Ca2þi ¼ 0:3 lM (for cbv1 + b1) and 10 lM (for cbv1); LC, lithocholate; CHS, cholesterol. *P < 0.05 vs. POPE/POPS bilayer;
**P < 0.01 vs. POPE/POPS bilayer.
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applied to the intracellular side of inside-out (I/O) patches at
a concentration of 150 lM, which is known to activate
(EC90) both recombinant and native BK channels [10,11]. All
experiments were performed at 10 lM free [Ca2+]i, which is
detected in the vicinity of the BK channel in arterial myocytes
[21]. Taking advantage that LC action on BK channels is
voltage-independent [11], records were obtained with the mem-
brane potential clamped within 40 and +20 mV to obtain
similar basal (i.e., in absence of LC) NPo values across
patches. Functional expression of a given chimeric b was deter-
mined by the channel response to Ibtx block in O/O patches,
which is blunted by extracellular loops of the b4-type [22] (Sup-
plementary Fig. 4).
Characteristically, LC caused an increase in cbv1 + B1L4
NPo >·2 times (n = 6; Fig. 2B and C). In contrast, LC consis-
tently failed to modify cbv1 + B4L1 NPo (n = 4; Fig. 2B and
C). Thus, the b1 extracellular loop is not necessary for this sub-
unit to provide LC sensitivity to the BK channel. Rather, any
possible b1 subunit LC-sensor is located in transmembrane-
intracellular domains.
We next coexpressed cbv1 with chimeric b1/b4 that had their
transmembrane domains swapped (‘‘B4TMs1’’ and ‘‘B1TMs4’’;
Fig. 3A). Functional expression of a given chimera was deter-mined by evaluating the Ibtx sensitivity of the channel (Supple-
mentary Fig. 4). Under conditions identical to those described
in the previous section, LC characteristically increased
cbv1 + B4TMs1 NPo ·2.4 times (n = 4; Fig. 3B and C). In
contrast, LC consistently failed to modify cbv1 + B1TMs4
NPo (n = 4; Fig. 3B and C). Therefore, the intracellular ends
of b1 are not critical in LC-sensing, but the subunit transmem-
brane regions include the LC sensor.
To determine which, if any, transmembrane domain of the
BK b1 is suﬃcient to provide LC-sensitivity to the channel,
we next constructed chimeric b4 containing either TM1
(‘‘B4TM11’’) or TM2 (‘‘B4TM21’’) from b1 (Fig. 4A). Func-
tional coexpression of these chimeras with cbv1 was conﬁrmed
by the resistance of the heteromeric channel-mediated currents
to Ibtx (Supplementary Fig. 4). In ﬁve out of ﬁve patches, LC
failed to increase cbv1 + B4TM11 NPo, indicating that b1 TM1
is not suﬃcient to provide LC-sensitivity to the channel
(Fig. 4B and C). In contrast, LC reversibly increased
cbv1 + B4TM21 NPo in every patch studied (n = 6), with an
average increase of ·2 times over control (Fig. 4B and C).
Moreover, cbv1 + B4TM21 responses to LC were similar to
those of cbv1 + wt b1 (Fig. 4D), which pinpoints TM2 as the
b1 protein domain that senses LC presence rendering acti-
vation of BK channels.
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Fig. 2. The BK b1 extracellular loop is not involved in lithocholate sensing. (A) Cartoon showing the b1/b4 chimeras constructed by swapping their
extracellular loops. L = extracellular loop; B = background region (i.e., transmembrane domains + cytosolic ends). Regions from b1 are given in
black while those from b4 are in grey. (B) Inside-out patch-clamp recordings demonstrate that lithocholate activates cbv1 + B1L4 (top) but not
cbv1 + B4L1 (bottom) channels. V = 30 mV; symmetric Ca2+ = 10 lM. (C) Averaged channel responses to LC. **P < 0.01 vs. vehicle-containing
solution; n = 6 (B1L4), n = 4 (B4L1).
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Non-genomic eﬀects of steroids are receiving increasing
attention as they may lead to discovery of novel receptorprotein sites, with possible development of steroid analogs
that have therapeutic use. Most steroids that are critical in
human physiology and disease, including bile acids, can
modify smooth muscle tone independently of genomic
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Fig. 4. b1 TM2 is the BK channel lithocholate sensor. (A) Cartoon showing chimeric subunits that contain either TM1 or TM2 from b1 on a b4
background (B = the rest of the protein). Regions from b1 are given in black, those from b4 are in grey. (B) Inside-out patch-clamp recordings
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cbv1 + B4TM21 (n = 6) and cbv1 + wt b1 (n = 7) are identical.
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gens, gluco- and mineralocorticoids, progestagens, bile acids
and cholesterol can all directly (i.e., independently of cell
integrity or metabolism) modify the activity of BK channels,
an action that explains or, at least, contributes to, the
myogenic eﬀect of these steroids. In contrast to bile acid data
[11], we show here that the activity of BK channels cloned
from vascular smooth muscle is modulated by cholesterol
independently of BK b1 (Fig. 1). This subunit is also unnec-
essary for tamoxifen [23] or 17b-estradiol direct activation
of BK channels, with a + b2, a + b4 [24] or just a [25] sub-
units being suﬃcient for estrogen action. In turn, cortico-
sterone activates more eﬀectively b4- than b2-containing
BK channels while dehydroepiandrosterone shows an oppo-
site selectivity and testosterone appears not to discriminate
among these two subunits [24]. In contrast, LC concentra-
tions that are maximally eﬀective in activating cbv1 + b1
completely fail to modulate cbv1 + b4 [11]. Therefore, b1
TM2 should be considered as a rather speciﬁc bile acid-
recognizing, instead of a non-selective, steroid-sensing, protein
domain.Among physiological steroids, LC and analogs are distinc-
tively planar amphiphiles, with a convex hydrophobic and a
concave hydrophilic hemisphere in the bile acid ring structure.
Remarkably, planar polarity is critical for bile acids to activate
smooth muscle BK channels [10]. In LC, polarity is provided
by the carboxylate in the side chain and the single hydroxyl
attached to the steroid ring. Based on data with diﬀerent bile
acid analogs and electrophysiological determinations, we
advanced a putative model in which LC inserted normally to
the bilayer plane, with LC ionized carboxylate pointing away
from the bilayer core, the convex hemisphere facing the bilayer
leaﬂets and the concave hemisphere facing the channel
subunit(s) [10,11]. In absence of structural data, we cannot
determine the contribution of channel slo1 and b1 subunits,
or even yet-to-be identiﬁed accessory proteins, if any, to the
LC actual binding site. However, pharmacological constraints,
including stereospeciﬁcity in LC activation of native BK chan-
nels containing b1 subunits [10] are consistent with the idea
that the b1 TM2 domain, at least, contributes to the LC
binding site. If so, and following the LC insertion model
mentioned above, the BK b1 TM2 domain should provide
678 A.N. Bukiya et al. / FEBS Letters 582 (2008) 673–678distinct interacting amino acid residues for the hydroxyl and/or
the concave hydrophobic ring area of LC. Notably, b1 con-
tains several Thr/Ser residues in TM2 that could interact with
the LC hydroxyl via hydrogen bonding. In contrast, BK b4,
which fails to sense LC [11], largely lacks these polar residues
in its TMs. The bile acid-sensing domain discovered here also
contains a much larger proportion of hydrophobic amino acids
(82%) than TM1. Remarkably, BK channel activation by bile
acids strongly correlates with the hydrophobicity of the steroi-
dal nucleus, LC being the most eﬀective activator [10]. While
identiﬁcation of the several amino acids that interact with
LC requires further study, present results clearly demonstrate
that b1 TM2 is a selective LC docking domain.
The newly discovered bile acid sensor contains 23 amino
acid residues (157–178aa; Supplementary Fig. 3) Remarkably,
its protein sequence does not show major identity (<5%) with
any of the few bile acid-binding domains identiﬁed in other
proteins. In addition, BK b1 is highly expressed in smooth
muscle, and LC fails to activate BK channels that include
accessory bs other than b1 [26]. Therefore, BK b1 TM2 may
serve as a ‘‘selective conduit’’ that allows bile acids (and even-
tual synthetic analogs) to modulate BK channels only in
tissues where b1 is abundant, such as smooth muscle.
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